Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Pharmacoeconomics|June 8, 2002
Estimating the effect of changes in body mass index on health state preferencesZafar Hakim, Anne Wolf, Louis P Garrison
Health Affairs (Project Hope)|September 13, 2006
Linking pharmacogenetics-based diagnostics and drugs for personalized medicineLouis P Garrison, M J Finley Austin
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 6, 2022
Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the "Age of Cures" and Their Implications for Dynamic EfficiencyLouis P Garrison, Boshen Jiao, Omar Dabbous
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Differential pricing of new pharmaceuticals in lower income European countriesZoltán Kaló, Lieven Annemans, Louis P Garrison
Journal of Managed Care & Specialty Pharmacy|April 28, 2021
Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapiesLouis P Garrison, Boshen Jiao, Omar Dabbous
Health Affairs (Project Hope)|May 9, 2007
Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysisLouis P Garrison, Adrian Towse, Brian W Bresnahan
Pharmacoeconomics|July 12, 2017
Performance-Based Risk-Sharing Arrangements: An Updated International ReviewJosh J Carlson, Shuxian Chen, Louis P Garrison
Journal for Immunotherapy of Cancer|September 5, 2019
Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of CancerPeter Paul Yu, Omar Eton, Louis P Garrison
The American Journal of Cardiology|January 8, 2011
Patient characteristics and medical care costs associated with hypertriglyceridemiaGregory A Nichols, Bhakti Arondekar, Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness AnalysisLouis P Garrison, Sachin Kamal-Bahl, Adrian Towse
Pageof 19